Aileron Therapeutics, Inc. (ALRN) Financial Statements (2024 and earlier)

Company Profile

Business Address 738 MAIN STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21,242,00045,933,00013,805,00018,278,00020,695,00050,752,000
Cash and cash equivalents5,194,0003,600,0007,046,0005,311,00010,635,00011,863,000
Short-term investments 16,048,00042,333,0006,759,00012,967,00010,060,00038,889,000
Restricted cash and investments25,00025,000593,00025,00025,00088,000
Other undisclosed current assets606,0002,219,0001,928,0001,247,0001,055,0001,000,000
Total current assets:21,873,00048,177,00016,326,00019,550,00021,775,00051,840,000
Noncurrent Assets
Operating lease, right-of-use asset 40,000152,000 6,060,000
Property, plant and equipment70,000128,00015,000295,0007,290,000154,000
Restricted cash and investments    568,000568,000 
Other noncurrent assets 24,00024,000  679,000694,000
Total noncurrent assets:134,000304,00015,0006,923,0008,537,000848,000
TOTAL ASSETS:22,007,00048,481,00016,341,00026,473,00030,312,00052,688,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,637,0002,780,0002,653,0003,368,0003,640,0003,256,000
Employee-related liabilities1,182,000922,0001,281,0001,473,0001,120,000
Accounts payable1,720,0001,210,0001,596,0001,452,0001,731,0001,600,000
Accrued liabilities917,000388,000135,000635,000436,000536,000
Debt    446,000  
Restructuring reserve      
Other undisclosed current liabilities747,0001,728,0001,307,0002,025,0001,730,0001,635,000
Total current liabilities:3,384,0004,508,0003,960,0005,839,0005,370,0004,891,000
Noncurrent Liabilities
Long-term debt and lease obligation  69,000 4,586,0005,342,000 
Long-term debt, excluding current maturities     5,342,000 
Operating lease, liability  69,000 4,586,000
Other undisclosed noncurrent liabilities  (69,000)219,000   
Total noncurrent liabilities:  69,000219,0004,586,0005,342,000 
Total liabilities:3,384,0004,577,0004,179,00010,425,00010,712,0004,891,000
Equity
Equity, attributable to parent18,623,00043,904,00012,162,00016,048,00019,600,00047,797,000
Common stock91,00091,00044,00028,00015,00015,000
Additional paid in capital291,365,000289,282,000231,412,000214,148,000188,083,000184,761,000
Accumulated other comprehensive income (loss) (48,000)(13,000)(2,000)7,000(5,000)(33,000)
Accumulated deficit(272,785,000)(245,456,000)(219,292,000)(198,135,000)(168,493,000)(136,946,000)
Total equity:18,623,00043,904,00012,162,00016,048,00019,600,00047,797,000
TOTAL LIABILITIES AND EQUITY:22,007,00048,481,00016,341,00026,473,00030,312,00052,688,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(27,647,000)(26,605,000)(20,496,000)(29,956,000)(31,902,000)(23,008,000)
Operating loss:(27,647,000)(26,605,000)(20,496,000)(29,956,000)(31,902,000)(23,008,000)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
318,000441,000(661,000)   
Loss from continuing operations:(27,329,000)(26,164,000)(21,157,000)(29,956,000)(31,902,000)(23,008,000)
Loss before gain (loss) on sale of properties:(26,164,000)(21,157,000)(29,956,000)(31,902,000)(23,008,000)
Other undisclosed net income (loss)   587,000355,000 
Net loss:(27,329,000)(26,164,000)(21,157,000)(29,369,000)(31,547,000)(23,008,000)
Other undisclosed net income attributable to parent     404,000
Net loss attributable to parent:(27,329,000)(26,164,000)(21,157,000)(29,369,000)(31,547,000)(22,604,000)
Preferred stock dividends and other adjustments      (41,000)
Net loss available to common stockholders, diluted:(27,329,000)(26,164,000)(21,157,000)(29,369,000)(31,547,000)(22,645,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(27,329,000)(26,164,000)(21,157,000)(29,369,000)(31,547,000)(23,008,000)
Comprehensive loss:(27,329,000)(26,164,000)(21,157,000)(29,369,000)(31,547,000)(23,008,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(35,000)(11,000)(9,000)12,00028,000371,000
Comprehensive loss, net of tax, attributable to parent:(27,364,000)(26,175,000)(21,166,000)(29,357,000)(31,519,000)(22,637,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: